Journal of Surgery

Estimated Glycemic Confidence Interval in Determining the Quality of a Graft after Venous Occlusion of the Pedicle in Rats

by Alexandre Yoiti Aoyagui*, Marcela Fernandes, Sandra Gomes Valente, Celso Kiyoshi Hirakawa, Luis Renato Nakachima, Joao Carlos Belloti, João Baptista Gomes dos Santos, Flávio Faloppa

Universidade Federal de São Paulo (UNIFESP), R. Borges Lagoa, 778 - Vila Clementino, São Paulo - SP, 04038-001, Brazil

*Corresponding author: Alexandre Yoti Aoyagui, Universidade Federal de São Paulo (UNIFESP), R. Borges Lagoa, 778 - Vila Clementino, São Paulo - SP, 04038-001, Brazil.

Received Date: 19 May 2024

Accepted Date: 28 May 2024

Published Date: 30 May 2024

Citation: Aoyagui AY, Fernandes M, Valente SG, Hirakawa CK, Nakachima LR, et al. (2024) Estimated Glycemic Confidence Interval in Determining the Quality of a Graft after Venous Occlusion of the Pedicle in Rats. J Surg 9: 11061 https://doi.org/10.29011/2575-9760.11061

Introduction

Currently, the flaps used to cover complex wounds are subject to failure in the event of occlusion of the vascular pedicle. Fortunately, the flap can be saved if revascularization only briefly occurs [1,2]. For this reason, postoperative monitoring has been highlighted as a key parameter in early identification of these cases. Among these, the parameters that always stood out in the literature were a) color, b) temperature, c) turgor, and d) bleeding scarified edges. However, the time interval between the occurrence of occlusion and clinical signs may delay the diagnosis. In this context, several authors have introduced the evaluation of patchwork complex measures with hand-specific work and costly measures such as Doppler ultrasound of the vascular pedicle [3-5], measurement of tissue oxygenation, intra-arterial or intravenous catheters, microdialysis [6], changes in metabolism [7,8], and evaluation with probes for thermal diffusion [9]. However, another measure that is also studied, and is less complex, is blood serum glucose, the point of interest in this study.

Decreases in glucose serum levels and glycogen storage occur early in the flaps with a good prognosis [10], returning to normal by the seventh day after the procedure. In pathological cases, where there is formation of clots or thrombi, a decrease in flap sugar levels is more pronounced, more frequently observed in congestion situations (venous involvement), and also in ischemia or both [11-13]. Even with the use of anticoagulants, clot formation can occur [14]. Following this line of reasoning, glycemic measures can be used to monitor flaps and decrease rate in blood glucose values would be indicative of occlusive changes in the pedicle [15]. In the literature, there have been statements about flap monitoring using an absolute glycemic measure, which can be hard to rely on because the established relationship values are influenced by systemic glucose concentration, which can vary among individuals. With continuous monitoring, the high cost becomes unfeasible in most of the healthcare centers worldwide. For these reasons, the aim of this study was to establish a confidence limit interval to determine the extent of flap distress, taking into account the glycemic measures by measurement with glucometers available in almost all hospitals, which reduces costs and facilitates the specificity and dissemination of this evaluation, which is important in grafts.

Materials and Methods

This experiment was conducted in the laboratory of Microsurgery of the Hand and Upper Limb Department of Orthopedics and Traumatology of a Surgery reference center in Brazil, approved by the internal ethics committee (972,081,013). For the development of the project we used male Wistar rats of the isogenic strain SHR (N = 20, age = 2.5 months, body weight = 280– 300 g), provided by the Experimental Models Development Center for Medicine and Biology of the Federal University São Paulo (CEDEME–UNIFESP). During the study, the experimental animals were kept in a vivarium, with light/dark cycle (12 h:12 h), temperature of 21 ± 2°C, receiving water and standard rat chow ad libitum.

Anesthesia

The animals were anesthetized by intra-peritoneal injection with xylazine anesthetic solution composed by 1 U/100g and ketamine 1 U/100g.

They were divided into two homogeneous groups. They underwent surgery to establish an inguinal flap where the systemic blood glucose levels were measured (via flow) and at the flap edge.

Groups:

  • Exposed: 10 SHRs underwent surgery for inguinal flap dissection, followed by occlusion of the pedicle vein.
  • Controls: 10 SHRs underwent surgery for inguinal flap dissection, leaving an intact pedicle.

Surgical Technique

Once anesthetized, the animals were submitted to trichotomy of the abdominal region at the level of the knee, with the group assignment randomly chosen. The antisepsis in incised locations was achieved with 70% alcohol. The rat was placed supine and the legs were fixed to the table plane, with a tape. Based on the femoral artery, an inguinal flap, measuring 3 cm long and 2 cm wide, was drawn parallel to the midline, including the femoral artery inside. Then, the skin was incised, followed by blunt dissection of the planes on the medial side, exposing the femoral artery and its branch to the inguinal flap. After exposure of the pedicle (measuring approximately 2 cm with an outside diameter of the vessel of at most 2 mm), the flap was dissected from the cranial portion to flow, isolating the vascular pedicle. In the group in which the venous occlusion was performed, the vein was dissected at the emergence of the pedicle vessels and connected with Prolene 7-0. The surgical procedure was performed under 25x magnified view through a microscope.

Blood Glucose Measurement

Blood glucose level was measured in a drop of blood, both from the caudal vein of the animal (Figure 2B; through venipuncture needle) and at the flap edge (Figure 2A; through the inguinal flap edge fragment), with the aid of a specific Local device (Accu-Chek active; Roche Pharmaceutical Chemicals S/a) composed of sensitive strips for biochemical determination of glucose (Accu-Chek active glucotrend).

Samples were collected at different times, and the data recorded in a spreadsheet and displayed in graphs, as described below:

  1. 0 minutes–before connecting the vein;
  2. 30, 60, 90, and 120 minutes–after connecting the vein.

Statistical Analysis

Statistical analysis was performed using descriptive statistics such as mean, standard deviation, standard error (mean standard deviation), and correlation to the characterization of quantitative variables in the study population. In the tests for comparison of quantitative variables, we initially checked the normality by the Shapiro-Wilk test because the sample size was small. The Shapiro-Wilk test did not reject the hypothesis of normality (p > 0.05), indicating that the data (n = 20) are derived from a normal distribution, and therefore parametric tests can be used.

We used the paired t-test for comparisons between glucose measurements, and we used Student’s t test for comparisons between groups. A more refined analysis was performed using a linear models generalized test with repeated measures in order to check the influence over time, with a comparison of groups as well as checking group-time interactions. The results were expressed as mean, maximum, minimum, standard deviation, IC, risk factor, percentage, absolute values used for each test, and a p value < 0.05 was considered statistically significant.

Results

Experimental Data

Glycemic behavior of the groups was evaluated in three stages, first, as a function of time, comparing the groups (control vs. exposed) to measure the degree of flap distress, and a second analysis between glycemia collection sites (Local vs systemic) to observe the times at which they were correlated. In the final stages, the times that had a positive correlation were used to determine the range of glucose values of the Local test that might indicate the boundaries between healthy tissue and distress, expressed always as the percentage of the glycemic value of the commercial test in reference to the systemic blood glucose measurement.

Parametric Data Evaluation

To establish reliable indices in comparisons, we first established normality of the samples by using the Shapiro-Wilk normality test. Normality was not rejected for the variables investigated, with p > 0.05 (Table 1).

Glycemic Performance Evaluation of the Local Test

We observed that the glycemic index in the exposed group decreased over time, while in the control group it remained stable, characterized by a regular upward curve (Figure 1).

In the group of interest, this reduction was associated with disruption of blood flow as measured by the Local test, which caused a constant reduction in glycemic rates by exposing the tissue to hypoxia. Note that this variation was significant when comparing the exposed and control groups from 30 until 120 minutes (0, p = 0.985; 30 min, p = 0.01; 60 min, p = 0.002; 90 min, p <0.0001; 120 min, p = 0.001) (Table 2,3).

Evaluation of Systemic Glycemic Behavior

On comparing the groups for systemic measurement, there was no significant difference over time (0, p = 0.985; 30 min, p = 0.1; 60 min, p = 0.12; 90 min, p = 0.81; 120 min, p = 0.51) (Table 2,3 and Figure 2).

Correlation Between the Local and Systemic Tests

There was a positive correlation in the exposed group at three stages of evaluation, at time 30 minutes where a weak but positive correlation (r = 0.602) was observed, and at times 60 and 90 minutes, with a positive and strong correlation (r = 843 and r = 782, respectively) (Table 4,5) (Figures 3).

In the control group this correlation was positive only at 60 minutes (r = 664) and 90 minutes (r = 824) (Table 6 and 7) (Figures 3).

Local/Systemic Glucose Ratio

After determining the success of the experimental model, we evaluated the times when the glucose values of the Local test correlated with those of the systemic test, to establish the maximum rate, minimum, and average in groups according to the relationship of these two variables (Table 8, Figure 11). It was possible to determine, for this sample, below 50% (GR/GS×100) value on the retail test, indicating flap damage. Values above 60% indicated good quality of the flap, and those with values between 50 and 60% should be observed carefully.

 

Figure 1: Glucose flap per group versus time.

 

Figure 2: Systemic blood glucose level per group versus time.

 

Figure 3: Representation of the correlation between the Local and systemic test results in the exposed group and control, depending on the indicated time.

 

Figure 4: Flap length.

Figure 5: Flap width.

 

Figure 6. Flap and Pedicle dissection.    

Figure 7: Flap harvested isolated only for the pedicle.

Figure 8: Systemic blood glucose measument form the rat tail.

Figure 9: Flap blood glucose measument from the edge of the flap.

 

Figure 10: Flap pedicle interrupted.

 

Figure 11: Representation of minimum and maximum values of the groups, control and exposed, for the percentage of Local glycemic test results correlating with the systemic blood glucose test results.

Tests of Normality

Kolmogorov-Smirnova

Shapiro-Wilk

Statistic

df

Sig.

Statistic

df

Sig.

glic_ flap _0

0.121

20

0.200*

0.945

20

0.293

gilc_sist_0

0.158

20

0.200*

0.935

20

0.191

glic_ flap _30

0.12

20

0.200*

0.967

20

0.684

gilc_sist_30

0.18

20

0.088

0.947

20

0.317

glic_ flap _60

0.111

20

0.200*

0.947

20

0.318

gilc_sist_60

0.107

20

0.200*

0.974

20

0.838

glic_ flap _90

0.117

20

0.200*

0.952

20

0.396

gilc_sist_90

0.117

20

0.200*

0.969

20

0.73

glic_ flap _120

0.118

20

0.200*

0.936

20

0.202

gilc_sist_120

0.129

20

0.200*

0.938

20

0.224

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction

Mean

N

Std. Deviation

Std. Error Mean

p

Pair 1

glic_flap_0

147.85

20

42,450

9,492

0.095

glic_flap_120

187.75

20

83,449

18,660

 Pair 2

gilc_sist_0

223.6

20

40,329

9,018

<0.0001

gilc_sist_120

349.55

20

84,357

18,863

Table 1: Representation of the normality test data.

Paired Samples Correlations

N

Correlation

Sig.=p

Pair 1

glic_flap_0 & glic_flap _120

20

-0.217

0.359

Pair 2

gilc_sist_0 & gilc_sist_120

20

-0.25

0.287

Paired Samples Test

Paired Differences

t

df

Sig. (2-tailed)

Mean

Std. Deviation

Std. Error Mean

95% Confidence Interval of the Difference

Lower

Upper

Pair 1

glic_flap_0 - glic_flap_120

-39,900

1,01,496

22,695

-87,402

7,602

-1,758

19

0.095

Pair 2

gilc_sist_0 - gilc_sist_120

-1,25,950

1,02,198

22,852

-1,73,780

-78,120

-5,512

19

0

Table 2: Comparison between groups (control and exposed) depending on the times studied.

Paired Samples Statistics

Grupo

Mean

N

Std. Deviation

Std. Error Mean

p

Exposed

Pair 1

glic_ flap _0

153.5

10

50,069

15,833

0.466

glic_flap_120

131.4

10

50,154

15,860

Pair 2

gilc_sist_0

229.3

10

29,945

9,469

0.011

gilc_sist_120

346.6

10

98,747

31,226

Control

Pair 1

glic_ flap _0

142.2

10

35,020

11,074

0.001

glic_flap_120

244.1

10

71,622

22,649

Pair 2

gilc_sist_0

217.9

10

49,646

15,700

0.001

gilc_sist_120

352.5

10

72,474

22,918

Table 3: Representation of test values, confidence interval, and variations.

Paired Samples Correlations

Grupo

N

Correlation

Sig.

Exposed

Pair 1

glic_ flap _0 & glic_ flap _120

10

-0.676

0.032

Pair 2

gilc_sist_0 & gilc_sist_120

10

-0.486

0.154

Control

Pair 1

glic_ flap _0 & glic_ flap _120

10

0.312

0.380

Pair 2

gilc_sist_0 & gilc_sist_120

10

-0.089

0.806

Paired Samples Test

Grupo

Paired Differences

t

df

Sig. (2-tailed)

Mean

Std. Deviation

Std. Error Mean

95% Confidence Interval of the Difference

Lower

Upper

Exposed

Pair 1

glic_flap _0 - glic_flap_120

22,100

91,734

29,009

-43,523

87,723

.762

9

.466

Pair 2

gilc_sist_0 - gilc_sist_120

-1,17,300

1,16,294

36,775

-2,00,492

-34,108

-3,190

9

.011

Control

Pair 1

glic_flap_0 - glic_flap _120

-1,01,900

69,211

21,886

-1,51,410

-52,390

-4,656

9

.001

Pair 2

gilc_sist_0 - gilc_sist_120

-1,34,600

91,427

28,912

-2,00,003

-69,197

-4,656

9

.001

                               

Table 4: Analysis of paired data between systemic blood glucose value and Local blood glucose test results of the exposed groups at the evaluated times.

Mean blood glucose values by time and group

Flap Glycemia

Systemic Glycemia

Time

Group

0

30

60

90

120

0

30

60

90

120

Exposed

153.5

135.5

132.3

119.1

131.4

229.3

286.1

337.5

322.1

346.6

Control

142.2

192.8

223.4

241.3

244.1

217.9

280.4

304.3

329.2

352.5

Table 5: Analysis of the correlation between systemic value and Local test results of exposed groups at the evaluated times by Pearson index.

Group Statistics

Grupo

Mean

Std. Deviation

Std. Error Mean

p

glic_flap_0

Exposed

153.5

50,069

15,833

0.566

Control

142.2

35,020

11,074

gilc_sist_0

Exposed

229.3

29,945

9,469

0.542

Control

217.9

49,646

15,700

glic_flap_30

Exposed

135.5

52,926

16,737

0.01

Control

192.8

34,915

11,041

gilc_sist_30

Exposed

286.1

41,565

13,144

0.783

Control

280.4

49,151

15,543

glic_flap_60

Exposed

132.3

45,911

14,518

0.002

Control

223.4

61,965

19,595

gilc_sist_60

Exposed

337.5

62,477

19,757

0.272

Control

304.3

68,302

21,599

glic_flap_90

Exposed

119.1

36,336

11,491

<0.0001

Control

241.3

56,671

17,921

gilc_sist_90

Exposed

322.1

63,897

20,206

0.811

Control

329.2

66,824

21,132

glic_flap_120

Exposed

131.4

50,154

15,860

0.001

Control

244.1

71,622

22,649

gilc_sist_120

Exposed

346.6

98,747

31,226

0.881

Control

352.5

72,474

22,918

df

Sig. (2-tailed)

Mean Difference

Std. Error Difference

95% Confidence Interval of the Difference

Lower

Upper

18

0.566

11,300

19,322

-29,294

51,894

18

0.542

11,400

18,334

-27,119

49,919

18

0.01

-57,300

20,051

-99,425

-15,175

18

0.783

5,700

20,356

-37,065

48,465

18

0.002

-91,100

24,387

-142.33

-39,864

18

0.272

33,200

29,272

-28,298

94,698

18

0

-122.2

21,288

-166.92

-77,475

18

0.811

-7,100

29,237

-68,526

54,326

18

0.001

-112.7

27,650

-170.79

-54,610

18

0.881

-5,900

38,734

-87,278

75,478

                   

Table 6: Analysis of paired data between systemic blood glucose value and Local test results of the control group at the evaluated times.

Correlations (n=20)

glic_ flap _0

gilc_sist_0

glic_ flap _30

gilc_sist_30

glic_flap_60

gilc_sist_60

glic_flap_90

gilc_sist_90

glic_flap_120

gilc_sist_120

glic_flap_0

Pearson Correlation

1

0.151

0.335

.465*

0.054

-0.263

-0.224

-0.104

-0.217

0.095

Sig. (2-tailed)

0.525

0.148

0.039

0.821

0.262

0.343

0.662

0.359

0.689

N

20

20

20

20

20

20

20

20

20

20

gilc_sist_0

Pearson Correlation

0.151

1

0.045

0.146

0.063

0.232

-0.014

-0.128

0.108

-0.25

Sig. (2-tailed)

0.525

0.85

0.538

0.792

0.324

0.952

0.591

0.651

0.287

N

20

20

20

20

20

20

20

20

20

20

glic_ flap _30

Pearson Correlation

0.335

0.045

1

0.185

.527*

-0.145

.474*

0.096

0.289

-0.042

Sig. (2-tailed)

0.148

0.85

0.434

0.017

0.543

0.035

0.686

0.217

0.861

N

20

20

20

20

20

20

20

20

20

20

gilc_sist_30

Pearson Correlation

.465*

0.146

0.185

1

0.013

-0.107

-0.051

-0.248

-0.013

0.043

Sig. (2-tailed)

0.039

0.538

0.434

0.956

0.654

0.83

0.291

0.955

0.857

N

20

20

20

20

20

20

20

20

20

20

glic_ flap _60

Pearson Correlation

0.054

0.063

.527*

0.013

1

0.273

.732**

.468*

.735**

0.073

Sig. (2-tailed)

0.821

0.792

0.017

0.956

0.244

0

0.037

0

0.761

N

20

20

20

20

20

20

20

20

20

20

gilc_sist_60

Pearson Correlation

-0.263

0.232

-0.145

-0.107

0.273

1

0.093

.615**

0.252

0.049

Sig. (2-tailed)

0.262

0.324

0.543

0.654

0.244

0.695

0.004

0.284

0.837

N

20

20

20

20

20

20

20

20

20

20

glic_ flap _90

Pearson Correlation

-0.224

-0.014

.474*

-0.051

.732**

0.093

1

.472*

.834**

-0.084

Sig. (2-tailed)

0.343

0.952

0.035

0.83

0

0.695

0.035

0

0.726

N

20

20

20

20

20

20

20

20

20

20

gilc_sist_90

Pearson Correlation

-0.104

-0.128

0.096

-0.248

.468*

.615**

.472*

1

0.378

0.127

Sig. (2-tailed)

0.662

0.591

0.686

0.291

0.037

0.004

0.035

0.101

0.595

N

20

20

20

20

20

20

20

20

20

20

glic_ flap _120

Pearson Correlation

-0.217

0.108

0.289

-0.013

.735**

0.252

.834**

0.378

1

-0.01

Sig. (2-tailed)

0.359

0.651

0.217

0.955

0

0.284

0

0.101

0.966

N

20

20

20

20

20

20

20

20

20

20

gilc_sist_120

Pearson Correlation

0.095

-0.25

-0.042

0.043

0.073

0.049

-0.084

0.127

-0.01

1

Sig. (2-tailed)

0.689

0.287

0.861

0.857

0.761

0.837

0.726

0.595

0.966

N

20

20

20

20

20

20

20

20

20

20

                       

Table 7: Correlation analysis by Pearson index between systemic and Local blood glucose of control groups at the evaluated times.

Correlations

Grupo

glic_ret_0

gilc_sist_0

Exposed

Pearson Correlation

glic_ flap _0

1,000

0.039

gilc_sist_0

0.039

1,000

Sig. (1-tailed)

glic_ flap _0

.

0.457

gilc_sist_0

0.457

.

N

glic_ flap _0

10

10

gilc_sist_0

10

10

Control

Pearson Correlation

glic_ flap _0

1,000

0.239

gilc_sist_0

0.239

1,000

Sig. (1-tailed)

glic_ flap _0

.

0.253

gilc_sist_0

0.253

.

N

glic_ flap _0

10

10

gilc_sist_0

10

10

Correlations

Group

glic_ret_30

gilc_sist_30

Exposed

Pearson Correlation

glic_ flap _30

1,000

0.602

gilc_sist_30

0.602

1,000

Sig. (1-tailed)

glic_ flap _30

.

0.033

gilc_sist_30

0.033

.

N

glic_ flap _30

10

10

gilc_sist_30

10

10

Controle

Pearson Correlation

glic_ flap _30

1,000

-0.134

gilc_sist_30

-0.134

1,000

Sig. (1-tailed)

glic_ flap _30

.

0.356

gilc_sist_30

0.356

.

N

glic_ flap _30

10

10

gilc_sist_30

10

10

Correlations

Group

glic_ret_60

gilc_sist_60

Exposed

Pearson Correlation

glic_ flap _60

1,000

0.543

gilc_sist_60

0.543

1,000

Sig. (1-tailed)

glic_ flap _60

.

0.052

gilc_sist_60

0.052

.

N

glic_ flap _60

10

10

gilc_sist_60

10

10

Control

Pearson Correlation

glic_ flap _60

1,000

0.664

gilc_sist_60

0.664

1,000

Sig. (1-tailed)

glic_ flap _60

.

0.018

gilc_sist_60

0.018

.

N

glic_ flap _60

10

10

gilc_sist_60

10

10

Correlations

Group

glic_ret_90

gilc_sist_90

Exposed

Pearson Correlation

glic_ flap _90

1,000

0.582

gilc_sist_90

0.582

1,000

Sig. (1-tailed)

glic_ flap _90

.

0.039

gilc_sist_90

0.039

.

N

glic_ flap _90

10

10

gilc_sist_90

10

10

Control

Pearson Correlation

glic_ flap _90

1,000

0.824

gilc_sist_90

0.824

1,000

Sig. (1-tailed)

glic_ flap _90

.

0.002

gilc_sist_90

0.002

.

N

glic_ flap _90

10

10

gilc_sist_90

10

10

Correlations

Group

glic_ret_120

gilc_sist_120

Exposed

Pearson Correlation

glic_ flap _120

1,000

0.193

gilc_sist_120

0.193

1,000

Sig. (1-tailed)

glic_ flap _120

.

0.297

gilc_sist_120

0.297

.

N

glic_ flap _120

10

10

gilc_sist_120

10

10

Control

Pearson Correlation

glic_ flap _120

1,000

-0.284

gilc_sist_120

-0.284

1,000

Sig. (1-tailed)

glic_ flap _120

.

0.213

gilc_sist_120

0.213

.

N

glic_ flap _120

10

10

gilc_sist_120

10

10

                 

Table 8: Representative percentage of the glucose ratio of the Local test in relationship to the systemic test (GR/GS x100).

Discussion

Monitoring flaps has a fundamental role in the success of the surgery, in case of a new approach. Parameters such as color, turgor and perfusion, and temperature measurements by thermal diffusion poor can suggest flap distress. Considering the blood glucose as a parameter evaluation, we can detect possible failure earlier. Systemic blood glucose level presents variations throughout the day and throughout a surgical procedure. Likewise, the values found in the flaps may also be subject to the same variations. Studies have been conducted to determine the values on retail tests to be considered to indicate distress. Sitzman in 2010, using the retail test on vertical abdominal flaps in rats, studied the decrease in blood glucose level in flaps because of occlusion of both the arterial and venous system, and compared the values obtained for the same flap in contralateral operated rats. Assuming sensitivity and specificity of 100%, a decrease in blood glucose value ≥ 7 mg/dL/min or decreased blood glucose values ≥ 2 mg/dL/min was associated with the level < 118 mg/dL [12].Assessing the decrease in glucose level in the work by Sitzman, we realized that the curve follows a pattern similar to the flap glycemic index. Hjortdal 1991 and Cohen 1983 noted that Local test blood glucose values decreased, returning to normal values by the seventh day [16,17]. Hara in 2012, evaluating data from 33 free flaps in humans, found the absolute value of 62 mg/dL as the cutoff value from the ROC curve, determining a sensitivity of 88% and specificity of 82% for flap damage [15].

In this study comparing the blood glucose measurements in the flap and systemic determination of the flap glycemic index, our results suggest that monitoring can be performed in a comparative way, besides using the absolute measure. The results we found show that both viable flaps and those in distress have similar measures at time 0. However, after 30 minutes, the experimental group showed values indicating distress, which was also evident in the following times. Another interesting point was to establish an interval in which to observe the flap, where less than 50% value indicates distress, between 50 and 60% value should be carefully observed, and a value >60% indicates the flap has good indications for success, contrary to an absolute cutoff value, as indicated by Hara et al. The values found in this study may not match those of other species, despite being the model most frequently used, because of its resemblance to the human model, because our index were glucose levels relative to the percentages of retail test/glucose systemic test values, which can be a very interesting parameter to be studied in daily practice.

Conclusion

FGI may be used as a postoperative assessment tool to determine flap distress during an early stage in experimental models. In addition, it might be useful in clinical practice, but its specificity needs to be confirmed in humans as well.

References

  1. Bui DT, Cordeiro PG, Hu QY, Disa JJ, Pusic A, et al. (2007) Free flap reexploration: Indications, treatment, and outcomes in 1193 free flaps. Plast Reconstr Surg 119: 2092-2100.
  2. Kroll SS, Schusterman MA, Reece GP (1996) Timing of pedicle thrombosis and flap loss after free-tissue transfer. Plast Reconstr Surg 98: 1230-1233.
  3. Seres L, Makula E, Morvay Z, Borbely L (2002) Color Doppler ultrasound for monitoring free flaps in the head and neck region. J Craniofac Surg 13: 75e8.
  4. Few JW, Corral CJ, Fine NA, Dumanian GA (2001) Monitoring buried head and neck free flaps with high-resolution color duplex ultrasound. Plast Reconstr Surg 108: 709e12.
  5. Schon R, Schramm A, Gellrich NC, Maier W, Duker J, et al. (2003) Color duplex sonography for the monitoring of vascularized free bone flaps. Otolaryngol Head Neck Surg 129: 71e6.
  6. Delgado JM, DeFeudis FV, Roth RH, Ryugo DK, Mitruka BM (1972) Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther 198: 9e21.
  7. Nord AE, Rojdmark J, Wickman M (2002) Metabolism in pedicled and free TRAM flaps: a comparison using the microdialysis technique. Plast Reconstr 109: 664e73.
  8. Rojdmark J, Blomqvist L, Malm M, Adams-Ray B, Ungerstedt U (1998) Metabolism in myocutaneous flaps studied by in situ microdialysis. Scand J Plast Reconstr Surg Hand Surg 32: 27e34.
  9. Khot MB, Maitz PK, Phillips BR, Bowman HF, Pribaz JJ, et al. (2005) Thermal diffusion probe analysis of perfusion changes in vascular occlusions of rabbit pedicle flaps. Plast Reconstr Surg 115: 1103-1109.
  10. Hjortdal VE, Kjølseth D, Henriksen TB, Hansen ES, Møller N (1991) Fuel metabolism in a pig myocutaneous island flap model. Plast Reconstr Surg 88: 664-672.
  11. Sitzman TJ, Hanson SE, King TW, Gutowski KA (2010) Detection of Flap Venous and Arterial Occlusion Using Interstitial Glucose Monitoring in a Rodent Model. Plast Reconstr Surg 126: 71-79.
  12. Setälä LP, Korvenoja EM, Härmä MA, Alhava EM, Uusaro AV, et al. (2004) Glucose, lactate, and pyruvate response in an experimental model of microvascular flap ischemia and reperfusion. Microsurgery 24: 223e31.
  13. Su CT, Im MJ, Hoopes JE (1982) Tissue glucose and lactate following vascular occlusion in island skin flaps. Plast Reconstr Surg 70: 202205.
  14. Liao EC, Taghinia AH, Nguyen LP, Yueh JH, May JW, et al. (2008) Incidence of hematoma complication with heparin venous thrombosis prophylaxis after TRAM flap breast reconstruction. Plast Reconstr Surg 121: 1101-1107.
  15. Hisako Hara, Makoto Mihara, Takuya Iida, Mitsunaga Narushima, Isao Koshima (2012) Blood glucose measurement in flap monitoring for salvage of flaps from venous thrombosis. Plast Reconstr Surg 129(3):587e-589e.
  16. Cohen BE, Harmon CS, Phizackerley PJ (1983) Glucose metabolism in experimental skin flaps. Plast Reconstr Surg 71: 79-86.
  17. Im MJ, Su CT, Hoopes JE (1979) Metabolic adaptations in delayed skin flaps. Glucose utilization and hexokinase activity. Plast Reconstr Surg 64: 244-248.

© by the Authors & Gavin Publishers. This is an Open Access Journal Article Published Under Attribution-Share Alike CC BY-SA: Creative Commons Attribution-Share Alike 4.0 International License. Read More About Open Access Policy.

Update cookies preferences